$Madrigal Pharmaceuticals (MDGL.US)$rose some 15% Tuesday after Wolfe Research reportedly initiated coverage of the pharma firm with a "Outperform" rating. MDGL gained as much as 15.2% to a $294.44 intraday high after Wolfe lauded the company's breakthrough liver drug Rezdiffra, according to published reports. The U.S. Food and Drug Administration approved Rezdiffra in March as the first treatment fornonalcoholic steatoh...
Market Maverick77 : 你從 ATHA 看到什麼?
George Soros II Market Maverick77 : 正如他所提及的,飛凡的交易量
Market Maverick77 George Soros II : 好消息?
Stock_Drift 樓主 Market Maverick77 : 我看到它突破了0.54的支撐位。
yesyesyes : $Trio Petroleum (TPET.US)$
查看更多評論...